Weston, MA, United States of America

Sonny Abraham

This inventor holds 1 USPTO granted patent. Top assignee: Biotransplant, Inc.. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sonny Abraham: Innovator in Immunotherapy

Introduction

Sonny Abraham is a notable inventor based in Weston, MA (US). He has made significant contributions to the field of immunotherapy, particularly in the determination of antibody production against administered therapeutics. His innovative approach has the potential to enhance treatment efficacy for individuals receiving glycoprotein therapies.

Latest Patents

Sonny Abraham holds 1 patent for his invention titled "Determination of antibody production against administered therapeutic." This patent discloses a composition and method for determining the levels of specific immune responsiveness to a glycoprotein in individuals undergoing treatment. The method involves contacting a body fluid sample obtained from the individual prior to glycoprotein treatment with a modified glycoprotein, and subsequently observing the immune response in pre- and post-treatment samples.

Career Highlights

Sonny Abraham is currently associated with Biotransplant, Inc., where he continues to work on innovative solutions in the field of immunotherapy. His research and development efforts are aimed at improving patient outcomes through advanced therapeutic methods.

Collaborations

Some of his notable coworkers include Michel G Awwad and Mary E White-Scharf. Their collaborative efforts contribute to the ongoing advancements in immunotherapy and related fields.

Conclusion

Sonny Abraham's work exemplifies the impact of innovation in healthcare, particularly in the realm of immunotherapy. His contributions are paving the way for more effective treatments and better patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…